Ter Telgte A, Van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, De Leeuw FE. Cerebral small vessel disease: From a focal to a global perspective. Nat Rev Neurol. 2018;14:387–98.

Article  PubMed  Google Scholar 

Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw F-E, et al. Neuroimaging standards for research into small vessel disease-advances since 2013. Lancet Neurol. 2023;4422:2–4.

Google Scholar 

Appelman APA, Exalto LG, Van Der Graaf Y, Biessels GJ, Mali WPTM, Geerlings MI. White matter lesions and brain atrophy: More than shared risk factors? A systematic review Cerebrovascular Diseases. 2009;28:227–42.

Article  PubMed  Google Scholar 

Dickie DA, Karama S, Ritchie SJ, Cox SR, Sakka E, Royle NA, et al. Progression of White Matter Disease and Cortical Thinning Are Not Related in Older Community-Dwelling Subjects. Stroke. 2016;47:410–6.

Article  PubMed  PubMed Central  Google Scholar 

Fiford CM, Manning EN, Bartlett JW, Cash DM, Malone IB, Ridgway GR, et al. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy. Hippocampus. 2017;27:249–62.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lambert C, Benjamin P, Zeestraten E, Lawrence AJ, Barrick TR, Markus HS. Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease. Brain. 2016;139:1136–51.

Article  PubMed  PubMed Central  Google Scholar 

Bethlehem RAI, Seidlitz J, White SR, Vogel JW, Anderson KM, Adamson C, et al. Brain charts for the human lifespan. Nature. 2022;604:525–33.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Narvacan K, Treit S, Camicioli R, Martin W, Beaulieu C. Evolution of deep gray matter volume across the human lifespan. Hum Brain Mapp. 2017;38:3771–90.

Article  PubMed  PubMed Central  Google Scholar 

Jouvent E, Viswanathan A, Chabriat H. Cerebral atrophy in cerebrovascular disorders. J Neuroimaging. 2010;20(3):213–8. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1552-6569.2009.00370.x.

Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, et al. Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects. Neurology. 2005;64:1704–11.

Article  PubMed  CAS  Google Scholar 

Carmelli D, Swan GE, Reed T, Wolf PA, Miller BL, DeCarli C. Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology. 1999;52:1119–24.

Article  PubMed  CAS  Google Scholar 

Ong M, Foo H, Chander RJ, Wen MC, Au WL, Sitoh YY, et al. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson’s disease. J Neurol Sci. 2017;377:122–6. Available from: https://doi.org/10.1016/j.jns.2017.04.010

Xu J, Li Y, Lin H, Sinha R, Potenza MN. Body mass index correlates negatively with white matter integrity in the fornix and corpus callosum: A diffusion tensor imaging study. Hum Brain Mapp. 2013;34:1044–52.

Article  PubMed  Google Scholar 

Jochems ACC, Arteaga C, Chappell F, Ritakari T, Hooley M, Doubal F, et al. Longitudinal Changes of White Matter Hyperintensities in Sporadic Small Vessel Disease: A Systematic Review and Meta-analysis. Neurology. 2022;99:E2454–63.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wardlaw JM, Valdés Hernández MC, Muñoz-Maniega S. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc. 2015;4:001140.

Article  PubMed  Google Scholar 

Behl C. Apoptosis and alzheimer’s disease. J Neural Transm. 2000;107(11):1325–44. Available from: http://link.springer.com/10.1007/s007020070021.

Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6:22.

Article  PubMed  PubMed Central  Google Scholar 

Obulesu M, Lakshmi MJ. Apoptosis in Alzheimer’s Disease: An Understanding of the Physiology. Pathology and Therapeutic Avenues Neurochem Res. 2014;39:2301–12.

PubMed  CAS  Google Scholar 

Jouvent E, Mangin JF, Duchesnay E, Porcher R, Düring M, Mewald Y, et al. Longitudinal changes of cortical morphology in CADASIL. Neurobiol Aging. 2012;33:1002.e29–1002.e36. Available from: https://doi.org/10.1016/j.neurobiolaging.2011.09.013

Brown WR, Moody DM, Thore CR, Challa VR. Apoptosis in leukoaraiosis. Am J Neuroradiol. 2000;21:79–82.

PubMed  PubMed Central  CAS  Google Scholar 

Wen W, Sachdev PS, Chen X, Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: A voxel-based morphometric study in a large epidemiological sample. Neuroimage. 2006;29:1031–9.

Article  PubMed  Google Scholar 

Kim SE, Kim HJ, Jang H, Weiner MW, DeCarli C, Na DL, et al. Interaction between alzheimer’s disease and cerebral small vessel disease: A review focused on neuroimaging markers. Int J Mol Sci. 2022;23(18):10490. Available from: https://www.mdpi.com/1422-0067/23/18/10490.

Article  CAS  Google Scholar 

Dadar M, Manera AL, Ducharme S, Collins DL. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer’s disease and frontotemporal dementia. Neurobiol Aging. 2022;111:54–63. Available from: https://doi.org/10.1016/j.neurobiolaging.2021.11.007

Rizvi B, Lao PJ, Chesebro AG, Dworkin JD, Amarante E, Beato JM, et al. Association of regional white matter hyperintensities with longitudinal alzheimer-like pattern of neurodegeneration in older adults. JAMA Netw Open. 2021;4(10):e2125166. Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2784767.

Rizvi B, Sathishkumar M, Kim S, Márquez F, Granger SJ, Larson MS, et al. Posterior white matter hyperintensities are associated with reduced medial temporal lobe subregional integrity and long-term memory in older adults. Neuroimage Clin. 2023;37:103308.

Article  PubMed  Google Scholar 

Garnier-crussard A, Krolak-salmon P, Garnier-crussard A, Cotton F, Krolak-salmon P. White matter hyperintensities in Alzheimer ’ s disease : Beyond vascular contribution. Alzheimers Dement. 2023;19(8):3738–48.

Article  PubMed  Google Scholar 

Dalby RB, Eskildsen SF, Videbech P, Frandsen J, Mouridsen K, Sørensen L, et al. Oxygenation differs among white matter hyperintensities, intersected fiber tracts and unaffected white matter. Brain Commun. 2019;1:fcz033.

Article  PubMed  PubMed Central  Google Scholar 

Ungvari Z, Toth P, Tarantini S, Prodan CI, Sorond F, Merkely B, et al. Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol. 2021;17:639–54.

Article  PubMed  PubMed Central  Google Scholar 

van Veluw SJ, Arfanakis K, Schneider JA. Neuropathology of Vascular Brain Health: Insights from Ex Vivo Magnetic Resonance Imaging-Histopathology Studies in Cerebral Small Vessel Disease. Stroke. 2022;53:404–15.

Article  PubMed  PubMed Central  Google Scholar 

Mayer C, Frey BM, Schlemm E, Petersen M, Engelke K, Hanning U, et al. Linking cortical atrophy to white matter hyperintensities of presumed vascular origin. J Cereb Blood Flow Metab. 2021;41:1682–91.

Article  PubMed  Google Scholar 

McAleese KE, Firbank M, Dey M, Colloby SJ, Walker L, Johnson M, et al. Cortical tau load is associated with white matter hyperintensities. Acta Neuropathol Commun. 2015;3:60.

Article  PubMed  PubMed Central  Google Scholar 

McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, et al. Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathol. 2017;134:459–73.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shirzadi Z, Schultz SA, Yau W-YW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, et al. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. JAMA Neurol. 2023; Available from: https://jamanetwork.com/journals/jamaneurology/fullarticle/2810315

Salvadores N, Gerónimo-Olvera C, Court FA. Axonal Degeneration in AD: The Contribution of Aβ and Tau. Front Aging Neurosci. Frontiers Media S.A.; 2020.

Bernal J, Schreiber S, Menze I, Ostendorf A, Pfister M, Geisendörfer J, et al. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study. Alzheimers Res Ther. 2023;15.

Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimer’s and Dementia: Translational Research and Clinical Interventions. 2019;5:107–17.

PubMed  PubMed Central  Google Scholar 

Garnier-Crussard A, Bougacha S, Wirth M, Dautricourt S, Sherif S, Landeau B, et al. White matter hyperintensity topography in Alzheimer’s disease and links to cognition. Alzheimer’s and Dementia. 2022;18:422–33.

Article  PubMed  CAS  Google Scholar 

Pålhaugen L, Sudre CH, Tecelao S, Nakling A, Almdahl IS, Kalheim LF, et al. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns. J Cereb Blood Flow Metab. 2021;41:1162–74.

Article  PubMed